Physician

Theodore Affue, M.D.

According to 2025 Medicare claims, Theodore Affue, M.D. (NPI: 1386674000) practices urology in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is IMPERIAL VALLEY MULTI-SPECIALTY MEDICAL GROUP, INC. (NPI: 1700277647; TIN: 471749912) and primary practice location at 92243-3687.

Affue's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 858 traditional Medicare patients, billed 14,327 HCPCS/CPT codes, and received $630,608 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,029 prescription claims across 1,019 beneficiaries totaling $3,867,423 in drug costs, led by Xtandi (Enzalutamide). DME data shows 33 claims. Open Payments data shows 41 records totaling $1,684. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,411,381 to $3,867,423. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $8,527 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,216	15,031	$1,294,653
2016	1,984	11,876	$849,427
2017	1,845	26,198	$677,671
2018	1,628	11,640	$629,591
2019	1,464	12,110	$700,407
2020	1,165	10,496	$693,925
2021	1,066	10,220	$724,362
2022	1,051	12,152	$761,619
2023	996	15,027	$709,223
2024	858	14,327	$630,608

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,813	19,468	$1,411,381
2016	1,658	17,911	$1,187,779
2017	1,666	17,145	$1,137,674
2018	1,589	16,003	$1,006,519
2019	1,454	12,608	$2,569,599
2020	1,287	10,804	$5,690,827
2021	1,079	7,667	$4,721,174
2022	1,027	6,872	$4,813,933
2023	1,021	6,288	$4,318,698
2024	1,019	6,029	$3,867,423

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	57	426	$33,609
2016	50	393	$16,973
2017	49	339	$19,023
2018	29	257	$19,954
2019	12	85	$8,844
2020	12	66	$8,232
2021	N/R	46	$5,303
2022	N/R	32	$5,878
2023	N/R	31	$6,704
2024	N/R	33	$9,697

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	490	1,173	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	704	2,211	$67
99442	Telephone medical discussion with physician, 11-20 minutes	518	1,212	$49
51798	Ultrasound measurement of bladder capacity after voiding	463	1,019	$9
81000	Manual urinalysis test with examination using microscope, non-automated	641	2,108	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	184	5,520	$2,436,338
Nubeqa	Darolutamide	31	930	$407,291
Myrbetriq	Mirabegron	504	25,630	$383,535
Gemtesa	Vibegron	400	21,304	$342,676
Tamsulosin Hcl	Tamsulosin Hcl	1,293	82,682	$29,743

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	33	$9,697

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	41	$1,684	Teleflex LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Theodore Affue, M.D.?

Tedicare shows public-source Medicare data for Theodore Affue, M.D. (NPI 1386674000), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Theodore Affue, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Theodore Affue, M.D.?

Theodore Affue, M.D. is linked to IMPERIAL VALLEY MULTI-SPECIALTY MEDICAL GROUP, INC. (billing NPI 1700277647) in the available physician profile data.

Does Theodore Affue, M.D. have Open Payments data?

Theodore Affue, M.D. has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.